Ulrich J Sommer1, Clemens Heiser, Constanze Gahleitner, Raphael M Herr, Karl Hörmann, Joachim T Maurer, Boris A Stuck. 1. Department of Otorhinolaryngology, Head and Neck Surgery, Sleep Disorders Center, University Hospital Mannheim, Department of Otorhinolaryngology, University Hospital Klinikum rechts der Isar, Technische Universität München, Mannheim Institute of Public Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Essen University Hospital-Department of Otorhinolaryngology, Head and Neck Surgery.
Abstract
BACKGROUND:Obstructive sleep apnea (OSA) is a very common disorder (prevalence 2-7% in women, 7-14% in men). It impairs the quality of life and increases mortality. Conservative treatment with continuous positive airway pressure is highly effective, but patient compliance is variable. Surgical treatments are controversial, as only a few are supported by evidence from controlled clinical trials. METHODS:Adult patients with OSA, CPAP intolerance, and oropharyngeal obstruction were included in the trial. All underwent polysomnography (PSG) and were randomly allotted to one of two groups. Patients in the treatment group underwent tonsillectomy with uvulopalatopharyngoplasty (TE-UPPP) within one month. All patients had a follow-up PSG at three months, and all PSGs were evaluated in blinded fashion. The primary outcome variable was the apneahypopnea index (AHI) as determined by PSG. Other outcome variables were subjective symptoms (daytime sleepiness, quality of life), complications, and patient satisfaction. RESULTS:42 patents were included in the trial (23 in the treatment group, 19 in the control group). The baseline AHI was 35.7 ± 19.4/hr in the control group and 33.7 ± 14.6/hr in the treatment group. The corresponding figures at 3 months were 28.6 ± 19.4/hr in the control group and 15.4 ± 14.1/hr in the treatment group (p = 0.036). The intervention also led to significant improvement in daytime sleepiness and in snoring, according to the patients' and their bed partners' assessment. 97% of the patients who underwent surgery were satisfied with the outcome. 65% of them needed no further treatment for OSA. CONCLUSION:TE-UPPP significantly improved apnea/hypopnea, daytime sleepiness, and snoring compared to control (i.e., no) treatment. It is a safe and effective treatment for OSA..
RCT Entities:
BACKGROUND: Obstructive sleep apnea (OSA) is a very common disorder (prevalence 2-7% in women, 7-14% in men). It impairs the quality of life and increases mortality. Conservative treatment with continuous positive airway pressure is highly effective, but patient compliance is variable. Surgical treatments are controversial, as only a few are supported by evidence from controlled clinical trials. METHODS: Adult patients with OSA, CPAP intolerance, and oropharyngeal obstruction were included in the trial. All underwent polysomnography (PSG) and were randomly allotted to one of two groups. Patients in the treatment group underwent tonsillectomy with uvulopalatopharyngoplasty (TE-UPPP) within one month. All patients had a follow-up PSG at three months, and all PSGs were evaluated in blinded fashion. The primary outcome variable was the apneahypopnea index (AHI) as determined by PSG. Other outcome variables were subjective symptoms (daytime sleepiness, quality of life), complications, and patient satisfaction. RESULTS: 42 patents were included in the trial (23 in the treatment group, 19 in the control group). The baseline AHI was 35.7 ± 19.4/hr in the control group and 33.7 ± 14.6/hr in the treatment group. The corresponding figures at 3 months were 28.6 ± 19.4/hr in the control group and 15.4 ± 14.1/hr in the treatment group (p = 0.036). The intervention also led to significant improvement in daytime sleepiness and in snoring, according to the patients' and their bed partners' assessment. 97% of the patients who underwent surgery were satisfied with the outcome. 65% of them needed no further treatment for OSA. CONCLUSION:TE-UPPP significantly improved apnea/hypopnea, daytime sleepiness, and snoring compared to control (i.e., no) treatment. It is a safe and effective treatment for OSA..
Authors: T E Weaver; A M Laizner; L K Evans; G Maislin; D K Chugh; K Lyon; P L Smith; A R Schwartz; S Redline; A I Pack; D F Dinges Journal: Sleep Date: 1997-10 Impact factor: 5.849
Authors: Robert L Owens; Bradley A Edwards; Danny J Eckert; Amy S Jordan; Scott A Sands; Atul Malhotra; David P White; Stephen H Loring; James P Butler; Andrew Wellman Journal: Sleep Date: 2015-06-01 Impact factor: 5.849
Authors: Kenny Peter Pang; Guillermo Plaza; Peter M Baptista J; Carlos O'Connor Reina; Yiong Huak Chan; Kathleen A Pang; Edward B Pang; Cybil Mei Zhi Wang; Brian Rotenberg Journal: Eur Arch Otorhinolaryngol Date: 2018-05-25 Impact factor: 2.503
Authors: Stuart MacKay; A Simon Carney; Peter G Catcheside; Ching Li Chai-Coetzer; Michael Chia; Peter A Cistulli; John-Charles Hodge; Andrew Jones; Billingsley Kaambwa; Richard Lewis; Eng H Ooi; Alison J Pinczel; Nigel McArdle; Guy Rees; Bhajan Singh; Nicholas Stow; Edward M Weaver; Richard J Woodman; Charmaine M Woods; Aeneas Yeo; R Doug McEvoy Journal: JAMA Date: 2020-09-22 Impact factor: 56.272